Several medications can lower cortisol levels or block cortisol’s effects in the body, but they’re prescribed specifically for people with endogenous Cushing’s syndrome, a condition where the body overproduces cortisol on its own. These aren’t medications you’d take for everyday stress-related cortisol spikes. They work through three distinct mechanisms: stopping the brain’s signal to produce cortisol, blocking cortisol production in the adrenal glands, or preventing cortisol from attaching to its receptors in the body.
When Cortisol-Lowering Medication Is Used
The Endocrine Society recommends surgery as the first-line treatment for Cushing’s syndrome, which is almost always caused by a tumor, either on the pituitary gland, adrenal glands, or elsewhere. Medications enter the picture when surgery isn’t an option, when a tumor can’t be located, or when surgery didn’t fully resolve the excess cortisol. In those cases, cortisol-lowering drugs serve as second-line treatment, sometimes used alongside radiation therapy to control symptoms while waiting for radiation to take full effect.
If your cortisol is elevated but you haven’t been diagnosed with Cushing’s syndrome, these medications wouldn’t be appropriate. Mildly elevated cortisol from chronic stress, sleep deprivation, or other lifestyle factors is managed differently, typically through behavioral changes rather than pharmacology.
Medications That Block Cortisol Production
The largest category of cortisol-lowering drugs works by interfering with the enzymes your adrenal glands need to manufacture cortisol. These are called steroidogenesis inhibitors, and they reduce the actual amount of cortisol circulating in your blood.
Osilodrostat is one of the more effective options available. It blocks an enzyme called 11-beta-hydroxylase, which handles one of the final steps in cortisol production. In the LINC 4 clinical trial, about 69% of patients achieved normal urinary cortisol levels by the end of the initial treatment period, and roughly 72% had normal levels at their final assessment during the extension phase. Most patients saw their cortisol drop to normal range within about 35 days of starting treatment.
Metyrapone targets the same enzyme but less potently. It has been used for decades and is often chosen when a faster-acting option is needed or as a bridge to surgery. Ketoconazole, originally developed as an antifungal drug, also suppresses cortisol production by blocking multiple enzymes involved in steroid manufacturing. Doses typically start around 200 to 600 mg per day and are gradually increased based on cortisol monitoring, with some patients eventually taking up to 1,200 mg daily.
Mitotane takes a more aggressive approach. Rather than simply blocking enzymes, it destroys adrenal gland cells in the zones responsible for cortisol production. This makes it particularly useful for adrenal cancer but also means its effects are harder to reverse. It’s a slow-acting drug that can take weeks to months to reach full effectiveness.
Medications That Target the Pituitary Gland
When Cushing’s syndrome is caused by a pituitary tumor (called Cushing’s disease specifically), some medications work upstream by reducing the hormone signal, ACTH, that tells the adrenal glands to produce cortisol in the first place. This approach targets the root cause rather than just suppressing the end product.
Pasireotide is FDA-approved for Cushing’s disease in adults when pituitary surgery isn’t possible or hasn’t worked. It binds to receptors on pituitary tumor cells and reduces their ACTH output, which in turn lowers cortisol. One significant drawback is that it frequently raises blood sugar levels, so people with diabetes or prediabetes need close glucose monitoring.
Cabergoline, a drug more commonly associated with treating high prolactin levels, is sometimes used off-label for Cushing’s disease. It activates dopamine receptors on pituitary tumor cells to suppress ACTH. Because both pasireotide and cabergoline act on the tumor itself, some clinicians combine them or pair one with an adrenal-targeted drug for patients who don’t respond adequately to a single medication.
Medications That Block Cortisol at the Receptor
Mifepristone (sold as Korlym for this use) takes a fundamentally different approach. Instead of reducing cortisol production, it blocks cortisol from binding to its receptor, essentially making cells deaf to cortisol’s signal. This is an important distinction: your cortisol blood levels stay the same or even rise, but the harmful effects of excess cortisol on your tissues are reduced.
This mechanism creates a practical challenge. Because cortisol levels don’t drop, doctors can’t use standard cortisol blood tests to monitor whether the drug is working. Instead, they track clinical improvements like blood sugar control and physical symptoms. Mifepristone is specifically approved for controlling high blood sugar caused by Cushing’s syndrome in patients with type 2 diabetes or glucose intolerance who aren’t candidates for surgery.
What Treatment Feels Like
All of these medications require regular monitoring, usually through urine or blood tests to check cortisol levels (except with mifepristone, where symptom tracking replaces lab values). Doses are adjusted gradually, often over weeks to months, based on how your cortisol responds. With ketoconazole, for example, cortisol is typically checked every one to four months, and the dose is bumped up in small increments until levels normalize.
The most common risk across all cortisol-lowering medications is overcorrection. If cortisol drops too low, you can develop adrenal insufficiency, which causes fatigue, muscle and joint pain, weakness, nausea, poor appetite, weight loss, and mood changes. Some treatment plans intentionally suppress cortisol fully and then add back a low replacement dose of a steroid to keep levels in a safe range. This “block and replace” strategy gives doctors more predictable control.
Liver function monitoring is particularly important with ketoconazole, which can cause liver toxicity. Osilodrostat can affect heart rhythm in some patients. Mitotane, because it destroys adrenal tissue, nearly always requires lifelong steroid replacement afterward. Each medication carries its own side effect profile, and the choice among them depends on the cause of the excess cortisol, how quickly levels need to come down, and what other health conditions you have.
How Long Medication Is Needed
For many people, cortisol-lowering medication is not a permanent solution but a bridge. It controls symptoms while waiting for radiation therapy to take effect (which can take months to years), before a planned surgery, or while doctors work to locate a hidden tumor. Some patients, however, remain on these drugs long-term if surgery isn’t an option or the underlying tumor can’t be removed entirely. In the LINC 4 trial extension, patients continued osilodrostat for well over a year with sustained cortisol control, suggesting these medications can remain effective over extended periods without losing their potency.
Stopping cortisol-lowering medication abruptly is dangerous. Tapering is essential to give the body’s hormonal feedback system time to recover, especially with drugs that have been suppressing cortisol for months. Your doctor will reduce doses gradually while monitoring for signs that your adrenal glands are resuming normal function.